Cytokine release from osteoblasts in response to ultrasound stimulation

Biomaterials

Volumn 24, Issue 13, 2003, Pages 2379-2385

  Li, J K ^a   Chang, W H ^a   Lin, J C ^a   Ruaan, R C ^a   Liu, H C ^b   Sun, J S ^b  

^a CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Interleukin; MTT assay; Osteoblast; Transforming growth factor (TGF); Tumor necrosis factor (TNF)

Indexed keywords

BONE; GROWTH KINETICS; ULTRASONIC EFFECTS;

MECHANICAL STIMULATION;

BIOMATERIALS;

CYTOKINE; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CULTURE MEDIUM; CYTOKINE RELEASE; EXPERIMENTAL MODEL; HYPOTHESIS; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; RAT; ULTRASOUND; UPREGULATION;

ANIMALIA;

EID: 0037409892     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00033-4     Document Type: Article

References (56)

1. 2. Calcif Tissue Int. 42:1988;261-266.
2. Buckly M.J., Banes A.J., Levin L.G., Sumpio B.E., Sato M Jordan R., Gilbert J., Link G.W., Tran Soy Tay R. Osteoblasts increase their rate of division and align in response to cyclic, mechanical tension in vitro. Bone Min. 4:1988;225-236.
3. Rubin J., Biskobing D., Fan X., Rubin C., McLeod K., Taylor W.R. Pressure regulates osteoclast formation and MCSF expression in marrow culture. J Cell Physiol. 170:1997;81-87.
4. Wolff J. The law of bone remodeling, translated by Maquet P and Furlong R. 1986;Springer, New York.
5. Klug W., Franke W.G., Knoch H.G. Scintigraphic control of bone-fracture healing under ultrasonic stimulation. an animal experimental study Eur J Nucl Med. 11:1986;494-497.
6. Pilla A.A., Mont M.A., Nasser P.R., Khan S.A., Figueiredo M., Kaufman J.J., Siffert R.S. Non-invasive low-intensity pulsed ultrasound accelerates bone healing in the rabbit. J Orthop Trauma. 4:1990;246-253.
7. Pilla A.A., Figueiredo M., Nasser P., Alves J.M., Ryaby J.T., Klein M., Kaufman J.J., Siffert R.S. Acceleration of bone repair by pulsed sine wave ultrasound. animal, clinical and mechanistic studies Brighton C.T., Pollack S.R. Electromagnetics in Medicine and Biology. 1991;331-341 San Francisco Press, San Francisco.
8. Tanzer M., Harvey E., Kay A., Morton P., Bobyn J.D. Effect of noninvasive low intensity ultrasound on bone growth into porous-coated implants. J Orthop Res. 14:1996;901-906.
9. Wang S.J., Lewallen D.G., Bolander M.E., Chao E.Y.S., Ilstrup D.M., Greenleaf J.F. Low intensity ultrasound treatment increases strength in a rat femoral fracture model. J Orthop Res. 12:1994;40-47.
10. Yang K.H., Wang S.J., Lewallen D.G., Greenleaf J., Oles K., Bronk J., Bolander M.E. Low intensity ultrasound stimulates fracture healing in rat model. biomechanical and gene expression analysis Trans Orthop Res Soc. 19:1994;519.
11. Yang K.H., Parvizi J., Wang S.J., Lewallen D.G., Kinnick R.R., Greenleaf J.F., Bolander M.E. Exposure to low intensity ultrasound increases aggrecan gene expression in a rat femur fracture model. J Orthop Res. 14:1996;802-809.
12. Ryaby J.T., Mathew J., Pilla A.A., Duarte-Alves P. Low-intensity pulsed ultrasound modulates adenylate cyclase activity and transforming growth factor beta synthesis. Brighton C.T., Pollack S.R. Electromagnetics in medicine and biology. 1991;95-100 San Francisco Press, San Francisco.
13. Knoch G.H., Klug W. Stimulation of fracture healing with ultrasound. Telger TC, translator. 1991;Springer, New York.
14. Xavier C.A.M., Duarte L.R. Estimulaca ultra-sonica decalo osseo. applicaca clinica Rev Bras Orthop. 18:1983;73-80.
15. Duarte L.R. The stimulation of bone growth by ultrasound. Arch Orthop Trauma Surg. 101:1983;153-159.
16. Chang W.H., Sun J.S., Chang S., Lin J.C. Study of Thermal effects of ultrasound stimulation on fracture healing. Bioelectromagnetics. 23:2002;256-263.
17. Sun J.S., Tsuang Y.H., Lin F.H., Liu H.C., Tsai C.Z., Chang W.H. Bone defect healing enhanced by ultrasound stimulation. an in vitro tissue culture model J Biomed Mater Res. 46:1999;253-261.
18. 2 secretion and growth of osteoblasts. Ultrasound Med Biol. 28(5):2002;683-690.
19. Sun J.S., Hong R.C., Chang W.H., Chen L.T., Lin F.H., Liu H.C. In vitro effects of low-intensity ultrasound stimulation on the bone cells. J Biomed Mater Res. 57:2001;449-456.
20. Parfitt A.M. Osteonal and hemi-osteonal remodeling. the spatial and temporal framework for signal traffic in adult human bone J Cell Biochem. 55:1994;273-286.
21. Eastell R., Delmas P.D., Hodgson S.F., Eriksen E.F., Mann K.G., Riggs B.L. Bone formation rate in older normal women. concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers J Clin Endocrinol Metab. 67:1988;741-748.
22. Gallagher J.C., Goldgar D., Moy A. Total bone calcium in normal women. effect of age and menopause status J Bone Miner Res. 2:1987;491-496.
23. Heaney R.P. Estrogen-calcium interactions in the postmenopause. a quantitative description Bone Miner. 11:1990;67-84.
24. Nordin B.E., Need A.G., Bridges A., Horowitz M. Relative contributions of years since menopause, age, and weight to vertebral density in postmenopausal women. J Clin Endocrinol Metab. 74:1992;20-23.
25. Parfitt A.M. The two-stage concept of bone loss revisited. Triangle. 31:1992;99-110.
26. Balena R., Toolan B.C., Shea M.et al. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest. 92:1993;2577-2586.
27. Poli V., Balena R., Fattori E.et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13:1994;1189-1196.
28. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15:1991;175-191.
29. Turner R.T., Wakley G.K., Hannon K.S., Bell N.H. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats. Endocrinology. 122:1988;1146-1150.
30. Kurihara N., Chenu C., Miller M., Civin C., Roodman G.D. Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology. 126:1990;2733-2741.
31. Hattersley G., Kerby J.A., Chambers T.J. Identification of osteoclast precursors in multilineage hemopoietic colonies. Endocrinology. 128:1991;259-262.
32. Marks Jr SC, Walker DG. Mammalian osteopetrosis - a model for studying cellular and humoral factors in bone resorption. In: Bourne GH, editor. The biochemistry and physiology of bone. 2nd ed. vol. 4. New York: Academic Press, 1976. p. 227-301.
33. Serke S., Sauberlich S., Abe Y., Huhn D. Analysis of CD34-positive hemopoietic progenitor cells from normal human adult peripheral blood. flow-cytometrical studies and in-vitro colony (CFU-GM, BFU-E) assays Ann Hematol. 62:1991;45-53.
34. Vermes C., Roebuck K.A., Chandrasekaran R., Dobai J.G., Jacobs J.J., Glant T.T. Particulate wear debris activates protein tyrosine kinases and nuclear factor-kappaB, which down-regulates type I collagen synthesis in human osteoblasts. J Bone Miner Res. 15:2000;1756-1765.
35. Dean D.D., Schwartz Z., Liu Y., Blanchard C.R., Agrawal C.M., Mabrey J.D., Sylvia V.L., Lohmann C.H., Boyan B.D. The effect of ultra-high molecular weight polyethylene wear debris on MG63 osteosarcoma cells in vitro. J Bone Joint Surg Am. 81:1999;452-461.
36. van der Plas A., Nijweide P.J. Isolation and purification of osteocytes. J Bone Miner Res. 7:1992;389-396.
37. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 89:1986;271-277.
38. Mosmann T. Rapid colorimetric assay for cellular growth and survival. application to proliferation and cytotoxicity assay J Immunol Methods. 65:1983;55-63.
39. Bonewald LF, Mundy GR. Role of transforming growth factor beta in bone remodeling: a review. [Review] (64 refs) Connect Tissue Res 1989;23(2-3):201-8.
40. Bonewald LF, Mundy GR. Role of transforming growth factor-beta in bone remodeling. [Review] (126 refs) Clin Orthop 1990;250:261-26.
41. Centrella M., McCarthy T.L., Canalis E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem. 262(6):1987;2869-2874.
42. Rosen D.M., Stempien S.A., Thompson A.Y., Seyedin S.M. Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro. J Cell Physiol. 134(3):1988;337-346.
43. Wrana J.L., Maeno M., Hawrylyshyn B., Yao K.L., Domenicucci C., Sodek J. Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations. J Cell Biol. 106(3):1988;915-924.
44. Sporn MB, Roberts AB. Transforming growth factor-beta. Multiple actions and potential clinical applications [clinical conference]. [Review] (28 refs) JAMA 1989;262(7):938-41.
45. Bostrom MP, Asnis P. Transforming growth factor beta in fracture repair. [Review] (46 refs) Clin Orthop 1998;(Suppl 355):S124-131.
46. Kassem M., Kveiborg M., Eriksen E.F. Production and action of transforming growth factor-beta in human osteoblast cultures. dependence on cell differentiation and modulation by calcitriol Eur J Clin Invest. 30(5):2000;429-437.
47. Peter S.J., Lu L., Kim D.J., Stamatas G.N., Miller M.J., Yaszemski M.J., Mikos A.G. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res. 50(3):2000;452-462.
48. Urano T., Yashiroda H., Muraoka M., Tanaka K., Hosoi T., Inoue S., Ouchi Y., Toyoshima H. p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1. J Biol Chem. 274(18):1999;12197-121200.
49. Kurihara N., Civin C., Roodman G.D. Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res. 6:1991;257-261.
50. Ishimi Y., Miyaura C., Jin C.H.et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 145:1990;3297-3303.
51. Lowik C.W., van der Pluijm G., Bloys H.et al. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells. a possible role of interleukin-6 in osteoclastogenesis Biochem Biophys Res Commun. 162:1989;1546-1552.
52. Armendariz-Borunda J., Katayama K., Seyer J.M. Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells. J Biol Chem. 267:1992;14316-14321.
53. Kouba D.J., Chung K.Y., Nishiyama T., Vindevoghel L., Kon A., Klement J.F., Uitto J., Mauviel A. Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts. J Immunol. 162:1999;4226-4234.
54. Greenfield E.M., Bi Y., Miyauchi A. Regulation of osteoclast activity. Life Sci. 65:1999;1087-1102.
55. Rifas L. Bone and cytokines. beyond IL-1, IL-6 and TNF-alpha [editorial] Calcif Tissue Int. 64:1999;1-7.
56. Lader C.S., Flanagan A.M. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Endocrinology. 139:1998;3157-3164.